Regulatory change can make or break a startup’s trajectory overnight. Dr Angela Jones, co-founder of Petscribers shares how the UK Competition and Markets Authority’s investigation into the veterinary sector validated their vision, flipped investor sentiment, and drove veterinary interest. 

Transitioning from stealth to commercial impact requires both capital and platform validation. Alexandros Pantalis, CEO of Phagos reflects on raising €25M Series A and the regulatory milestones that enabled first commercial sales of personalised phage-based veterinary medicines in France.

Partnerships can transform the trajectory of a health-tech startup. Johanna Majamaa, CEO of GekkoVet discusses how working with Royal Canin enabled the company to validate its platform across 100 clinics, demonstrate real-world impact, and lay the groundwork for expansion into new markets and universities.